HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,772,480 | +4.6% | 46,400 | -1.3% | 0.01% | +20.0% |
| Q2 2023 | $1,695,290 | -50.3% | 47,000 | -47.4% | 0.01% | -58.3% |
| Q1 2023 | $3,414,186 | -56.3% | 89,400 | -34.9% | 0.01% | -33.3% |
| Q4 2022 | $7,812,370 | +211.1% | 137,300 | +116.2% | 0.02% | +260.0% |
| Q3 2022 | $2,511,000 | -1.3% | 63,500 | +9.9% | 0.01% | +25.0% |
| Q2 2022 | $2,543,000 | +131.0% | 57,800 | +109.4% | 0.00% | +300.0% |
| Q1 2022 | $1,101,000 | -83.9% | 27,600 | -83.8% | 0.00% | -83.3% |
| Q4 2021 | $6,852,000 | +29.4% | 170,400 | +30.9% | 0.01% | 0.0% |
| Q3 2021 | $5,297,000 | -23.4% | 130,200 | -14.5% | 0.01% | -25.0% |
| Q2 2021 | $6,911,000 | +28.3% | 152,200 | +17.8% | 0.01% | 0.0% |
| Q1 2021 | $5,386,000 | -1.2% | 129,200 | +1.2% | 0.01% | -11.1% |
| Q4 2020 | $5,454,000 | +120.3% | 127,700 | +35.6% | 0.01% | +12.5% |
| Q3 2020 | $2,476,000 | -62.5% | 94,200 | -61.7% | 0.01% | -73.3% |
| Q2 2020 | $6,595,000 | +262.6% | 246,000 | +143.3% | 0.03% | +100.0% |
| Q1 2020 | $1,819,000 | -43.2% | 101,100 | -44.1% | 0.02% | -31.8% |
| Q4 2019 | $3,204,000 | +74.3% | 180,700 | +52.5% | 0.02% | +46.7% |
| Q3 2019 | $1,838,000 | -44.2% | 118,500 | -38.2% | 0.02% | -50.0% |
| Q2 2019 | $3,292,000 | -11.5% | 191,600 | -17.1% | 0.03% | -26.8% |
| Q1 2019 | $3,719,000 | -1.0% | 231,000 | -10.1% | 0.04% | +24.2% |
| Q4 2018 | $3,758,000 | +25.6% | 256,900 | +56.1% | 0.03% | +37.5% |
| Q3 2018 | $2,991,000 | +13.6% | 164,600 | +5.4% | 0.02% | +4.3% |
| Q2 2018 | $2,633,000 | -43.6% | 156,100 | -34.5% | 0.02% | -51.1% |
| Q1 2018 | $4,670,000 | -50.2% | 238,400 | -48.5% | 0.05% | -28.8% |
| Q4 2017 | $9,378,000 | +36.1% | 462,900 | +16.7% | 0.07% | +4.8% |
| Q3 2017 | $6,892,000 | +69.3% | 396,800 | +25.0% | 0.06% | +50.0% |
| Q2 2017 | $4,070,000 | +60.7% | 317,500 | +62.5% | 0.04% | +44.8% |
| Q1 2017 | $2,532,000 | +14.2% | 195,400 | -13.0% | 0.03% | +31.8% |
| Q4 2016 | $2,218,000 | +34.6% | 224,500 | +64.6% | 0.02% | +22.2% |
| Q3 2016 | $1,648,000 | +68.5% | 136,400 | +20.4% | 0.02% | +50.0% |
| Q2 2016 | $978,000 | +11.5% | 113,300 | +22.4% | 0.01% | 0.0% |
| Q1 2016 | $877,000 | -73.0% | 92,600 | -50.6% | 0.01% | -68.4% |
| Q4 2015 | $3,251,000 | +11.3% | 187,600 | -13.7% | 0.04% | -5.0% |
| Q3 2015 | $2,921,000 | -50.9% | 217,500 | -17.5% | 0.04% | -51.8% |
| Q2 2015 | $5,950,000 | +113.6% | 263,500 | +35.1% | 0.08% | +88.6% |
| Q1 2015 | $2,786,000 | +41.2% | 195,100 | -4.6% | 0.04% | +46.7% |
| Q4 2014 | $1,973,000 | -20.7% | 204,500 | -25.2% | 0.03% | -21.1% |
| Q3 2014 | $2,488,000 | +16.4% | 273,400 | +26.4% | 0.04% | +15.2% |
| Q2 2014 | $2,137,000 | -15.3% | 216,300 | +8.9% | 0.03% | -21.4% |
| Q1 2014 | $2,524,000 | -23.3% | 198,700 | -9.5% | 0.04% | -16.0% |
| Q4 2013 | $3,292,000 | +81.5% | 219,600 | +33.7% | 0.05% | +42.9% |
| Q3 2013 | $1,814,000 | -1.4% | 164,300 | -29.0% | 0.04% | -22.2% |
| Q2 2013 | $1,840,000 | – | 231,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 27,600 | $1,101,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,400 | $6,197,000 | 0.00% |
| SIMPLEX TRADING, LLC | 5,500 | $219,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |